BOU FAKHREDIN, RAYAN
BOU FAKHREDIN, RAYAN
Dipartimento di Scienze Cliniche e di Comunità
ELUCIDATING THE ROLE OF HET0016 IN AMELIORATING 20-HETE INDUCED OXIDATIVE STRESS AND LIVER INJURY IN B-THALASSEMIA: A NOVEL THERAPEUTIC TARGET
2025 R. BOU FAKHREDIN
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with transfusion-dependent β-thalassemia
2024 D.L. Panzieri, D. Consonni, N. Scaramellini, G. Ausenda, F. Granata, N. Caponio, L. Duca, S. Leoni, S. Elli, M. Ferraresi, V. Bolis, C. Curcio, M.A. Irrera, D. Maira, G. Graziadei, E. Cassinerio, M.D. Cappellini, R. Bou-Fakhredin, V. Brancaleoni, I. Motta
Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia
2024 S. Leoni, R. Bou Fakhredin, F. Granata, E. Cassinerio, M. Maggioni, A.L. Fracanzani, M.D. Cappellini, I. Motta
Step out of the shadows: a call for action for rare diseases
2024 F. Granata, R. Bou Fakhredin, M.D. Cappellini, I. Motta
Clinical complications and their management
2023 R. Bou-Fakhredin, I. Motta, M.D. Cappellini, A.T. Taher
Redox Balance in β-Thalassemia and Sickle Cell Disease: A Love and Hate Relationship
2022 R. Bou-Fakhredin, L. De Franceschi, I. Motta, A.A. Eid, A.T. Taher, M.D. Cappellini
Advancing the care of β-thalassaemia patients with novel therapies
2022 R. Bou-Fakhredin, I. Motta, M.D. Cappellini
Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective
2022 R. Bou-Fakhredin, L. De Franceschi, I. Motta, M.D. Cappellini, A.T. Taher
Care of patients with hemoglobin disorders during the COVID-19 pandemic: An overview of recommendations
2020 A.T. Taher, R. Bou-Fakhredin, F. Kreidieh, I. Motta, L. De Franceschi, M.D. Cappellini
Beta thalassemia : New therapeutic options beyond transfusion and iron chelation
2020 I. Motta, R. Bou-Fakhredin, A.T. Taher, M.D. Cappellini
Hypercoagulability and Vascular Disease
2018 A.T. Taher, M.D. Cappellini, R. Bou-Fakhredin, D. Coriu, K.M. Musallam
Non-transfusion-dependent thalassemia: An update on complications and management
2018 S. Joseph, T. Ali, B. Rayan, S. Antoine N., M.D. Cappellini, T. Ali T.
Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
2017 R. Bou-Fakhredin, A. Bazarbachi, B. Chaya, J. Sleiman, M..D. Cappellini, A..T. Taher